-->

live project

2 MBA/ PGDM students are needed who have completed their first year for a live project of a industry. Stipend would be paid. Interested one can write back @ rk.singal58@gmail.com

Tuesday, April 29, 2014


  

    Positive Thinking Lead to Positive Outcomes.

    Failure is a stepping stone to success.

    Help Yourself by Helping Others

    That Creates Synergy. Synergy Cements Trust

    Trust multiplies Confidence

    Hence, No Can stop you in reaching your destination.  

Wednesday, April 9, 2014

Monday, April 7, 2014



Sun Pharma to buy struggling Ranbaxy for $3.2 billion as Daiichi Sankyo retreats

TOKYO/MUMBAI Mon Apr 7, 2014 4:58pm IST
    
An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014. REUTERS-Danish Siddiqui
A man rides a motorcycle in front of the office of Ranbaxy Laboratories at Gurgaon, on the outskirts of New Delhi, June 13, 2013. REUTERS-Adnan Abidi-Files
1 of 2. An employee speaks on phone as he walks out of research and development centre of Sun Pharmaceutical Industries Ltd in Mumbai April 7, 2014.
Credit: Reuters/Danish Siddiqui

Related Topics

Stocks

 
Sun Pharmaceutical Industries Ltd
SUN.NS
Rs588.10
+16.30+2.85%
04/07/2014
 
Ranbaxy Laboratories Ltd
RANB.NS
Rs445.75
-13.80-3.00%
04/07/2014
 
Daiichi Sankyo Co Ltd
4568.T
¥1,813
+58.00+3.30%
04/07/2014

 

 
 
 
 





TOKYO/MUMBAI (Reuters) - Sun Pharmaceutical Industries Ltd (SUN.NS) has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd (RANB.NS) for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co (4568.T), and got Ranbaxy India-made drugs barred from the United States
 
Share

Receive Quality Tutorials and Latest Job Information from Dr. Singhal Straight in Your Inbox by Submitting Your Email ID Below

Your Information Will Never Be Shared.